Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 26;3(2):81-4.
doi: 10.1007/s12245-010-0175-y.

Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction

Matthew J Geraci, Stacey L McCoy, Paul M Crum, Rajnikant A Patel

Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction

Matthew J Geraci et al. Int J Emerg Med. .

Abstract

Background: With upwards of 48% of human immunodeficiency virus (HIV)-infected persons having a probable psychiatric disorder, the possibility of cross-class drug interactions causing adverse effects or fatalities exists.

Aims: This report discusses an emergent case of low-flow priapism caused by an interaction between a previously prescribed combination protease inhibitor (PI) and newly added antipsychotic medications.

Methods: A 50-year-old HIV-positive man on highly active antiretroviral therapy (HAART), including the combination PI, lopinavir/ritonavir (Kaletra((R))), experienced an episode of priapism hours after beginning two new antipsychotic medications. Quetiapine (Seroquel((R))) and perphenazine (Trilafon((R))) were added to treat a diagnosed schizoaffective disorder.

Results: The patient presented to the emergency department complaining of a constant, painful erection lasting approximately 42 h. Treatment with intracavernous ephedrine, irrigation, and aspiration helped achieve detumescence.

Conclusion: This case displays the immediate and detrimental effects due to the addition of antipsychotic medications to previously altered cytochrome P450 (CYP450) enzyme levels. The inhibition of CYP450 enzymes 3A4 and 2D6 by the combination PI, lopinavir/ritonavir, was likely the major culprit in causing greater than expected free levels of perphenazine and quetiapine resulting in priapism.

Keywords: Antipsychotic; Cytochrome P450; Drug interaction; HIV; Priapism; Protease inhibitor.

PubMed Disclaimer

References

    1. Repetto MJ, Petitto JM. Psychopharmacology in HIV-infected patients. Psychosom Med. 2008;70(5):585–592. doi: 10.1097/PSY.0b013e3181777190. - DOI - PubMed
    1. Ferrando SJ, Wapenyi K. Psychopharmacological treatment of patients with HIV and AIDS. Psychiatr Q. 2002;73(1):33–49. doi: 10.1023/A:1012840717735. - DOI - PubMed
    1. Sikka R, Magauran B, Ulrich A, Shannon M. Bench to bedside: pharmacogenomics, adverse drug interactions, and the cytochrome P450 system. Acad Emerg Med. 2005;12(12):1227–1235. doi: 10.1111/j.1553-2712.2005.tb01503.x. - DOI - PubMed
    1. Sood S, James W, Bailon MJ. Priapism associated with atypical antipsychotic medications: a review. Int Clin Psychopharmacol. 2008;23(1):9–17. doi: 10.1097/YIC.0b013e3282f1c1ef. - DOI - PubMed
    1. Casiano H, Globerman D, Enns MW. Recurrent priapism during treatment with clozapine, quetiapine and haloperidol. J Psychopharmacol. 2007;21(8):898–899. doi: 10.1177/0269881107077372. - DOI - PubMed